Biography

Dr. Yvonne Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto. She is a Professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto and directs the Genomics Health Services Research Program at St. Michael’s Hospital. Dr. Bombard holds the Canada Research Chair in Genomics Health Services and Policy. She sets research direction at national and international levels as Board Member of the American Society of Human Genetics and CIHR’s Institute of Genetics. Dr. Bombard advises on funding recommendations on emerging genetic testing technologies for Ontario. Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH) and also received a ‘Rising Star’ award from CIHR’s Institute of Health Services and Policy Research. She has been awarded a CIHR Foundation grant as an Early Career Investigator, CIHR Maud Menten Early Career Prize in Genetics and recently received Canadian Cancer Society’s early career investigator award for her work and policy change.

Recent Publications

  1. Sildva, T, Miller, E, Henry, A, Noel, K, Ahmed, S, Chowdhary, S et al.. Engaging for equity: Lessons from a cross-sector partnership addressing prostate cancer risk in the black community. Res Involv Engagem. 2025;11 (1):60. doi: 10.1186/s40900-025-00743-x. PubMed PMID:40495230 PubMed Central PMC12153116.
  2. Saeedi, S, Hirijkaka, D, Clausen, M, Luca, S, Reble, E, Kodida, R et al.. The development and usability of 'The Genetics Navigator': a digital solution for adult and paediatric clinical genetics services. Eur J Hum Genet. 2025; :. doi: 10.1038/s41431-025-01871-4. PubMed PMID:40447700 .
  3. Chan, KK, Takhar, P, Evans, WK, Mercer, RE, Denburg, A, Beca, J et al.. Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration. BMJ Open. 2025;15 (5):e096286. doi: 10.1136/bmjopen-2024-096286. PubMed PMID:40447425 PubMed Central PMC12128457.
  4. Jha, V, Saeedi, S, Clausen, M, Assamad, D, Grewal, S, Hirjikaka, D et al.. What are patient perspectives on privacy and trust in digital genomic tools? A qualitative study. J Genet Couns. 2025;34 (3):e70025. doi: 10.1002/jgc4.70025. PubMed PMID:40305239 PubMed Central PMC12043032.
  5. Adi-Wauran, E, Krishnapillai, S, Uleryk, E, Saeedi, S, Bombard, Y. Patient-centred care in precision oncology: A systematic review. Patient Educ Couns. 2025;136 :108753. doi: 10.1016/j.pec.2025.108753. PubMed PMID:40121935 .
  6. Allyse, MA, Agam, P, Bombard, Y, Feys, R, Horstmann, M, Kokayi, A et al.. Building Better Medicine: Translational Justice and the Quest for Equity in US Healthcare. Am J Bioeth. 2025;25 (6):11-25. doi: 10.1080/15265161.2025.2457713. PubMed PMID:39988785 PubMed Central PMC12143965.
  7. Clausen, M, Krishnapillai, S, Hirjikaka, D, Kodida, R, Shickh, S, Reble, E et al.. Genetics Adviser: The development and usability testing of a new patient digital health application to support clinical genomic testing. Genet Med Open. 2024;2 :101814. doi: 10.1016/j.gimo.2024.101814. PubMed PMID:39669596 PubMed Central PMC11613922.
  8. Shickh, S, Mighton, C, Clausen, M, Sam, J, Hirjikaka, D, Reble, E et al.. Clinical Utility of Genomic Sequencing for Hereditary Cancer Syndromes: An Observational Cohort Study. JCO Precis Oncol. 2024;8 :e2400407. doi: 10.1200/PO-24-00407. PubMed PMID:39666930 .
  9. Martyn, M, Lee, L, Jan, A, Tytherleigh, R, Lynch, F, Mighton, C et al.. Offering complex genomic screening in acute pediatric settings: Family decision-making and outcomes. Genet Med. 2025;27 (2):101327. doi: 10.1016/j.gim.2024.101327. PubMed PMID:39548854 .
  10. Mighton, C, Kodida, R, Shickh, S, Clausen, M, Reble, E, Sam, J et al.. Opportunistic genomic screening has clinical utility: An interventional cohort study. Genet Med. 2025;27 (2):101323. doi: 10.1016/j.gim.2024.101323. PubMed PMID:39530317 .
Search PubMed

Affiliations & Other Activities

  • Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Member, Board of Directors, American Society of Human Genetics
  • Member, CIHR Institute of Genetics Advisory Board
  • Member, Ontario Genetics Advisory Committee, Health Quality Ontario
  • Member, Board of Directors, Exactis Innovation
  • Associate, Ontario Institute of Cancer Research
  • Co-lead, Societal Values and Patient Engagement Program, the Canadian Centre for Applied Research in Cancer Control
  • Member, Provincial Council for Maternal and Child Health’s Prenatal Screening Advisory Committee
  • Member, Steering Committee of the Canadian Coalition for Genetic Fairness